ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,458, issued on April 21, was assigned to SYSTIMMUNE INC. (Redmond, Wash.). "Antibody-drug conjugate having acidic self-stabilization junct... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,459, issued on April 21, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.). "Protein-drug conjugates comprising camptotheci... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,460, issued on April 21, was assigned to GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seongnam-si, South Korea). "Stem c... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,461, issued on April 21, was assigned to Molly Sandra Shoichet (York, Canada). "Hydrogel compositions and uses thereof" was invented by Mo... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,462, issued on April 21, was assigned to University-Industry Cooperation Group of Kyung Hee University (Yongin-si, South Korea). "Porous s... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,463, issued on April 21, was assigned to The Johns Hopkins University (Baltimore). "Tolerogenic artificial antigen-presenting cells" was i... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,465, issued on April 21, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "AAV-NAGLU vectors for treat... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,466, issued on April 21, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Enhanced human opsin promote... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,467, issued on April 21, was assigned to SHANGHAI VITALGEN BIOPHARMA Co. LTD. (Shanghai). "Recombinant AAV vectors for treating neurodegen... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,468, issued on April 21, was assigned to Oregon Health & Science University (Portland, Ore.). "Oxazine-based fluorophore compounds for ner... Read More